alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1
                                                                      EXHIBIT 23


              CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


We have issued our reports dated February 27, 1998 (except for note 3, as to
which the date is April 2, 1998), accompanying the consolidated financial
statements and we have issued our report dated February 27, 1998 on Schedule II,
included in the Annual Report of Safety 1st, Inc. and Subsidiaries on Form 10-K
for the fiscal year ended January 3, 1998. We hereby consent to the
incorporation by reference of said reports in the Registration Statements of
Safety 1st, Inc. on Form S-8 (File No. 33-79332, effective May 26, 1994) and on
Forms S-3 (File Nos. 33-78970, effective May 19, 1994 and 33-95656, effective
August 21, 1995).


                                                     GRANT THORNTON LLP

Boston, Massachusetts
March 30, 1998
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO****18 U.S.C. SECTION 1350,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARABANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Fortune Partners Inc. (the “Company”) on Form 10-QSB for the nine months ended June 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Brock, President of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

| (1) | The Report fully complies with the requirements of section 13(a) and 15(d) of the Securities and Exchange Act of 1934; and                           |  |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|--|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |  |

| Dated: | July 21, 2005 | By: | //s// Paul Brock |  |
|--------|---------------|-----|------------------|--|
|        |               |     | Paul Brock       |  |
|        |               |     | President        |  |

----
IIB 

118TH CONGRESS 

2D SESSION H. R. 5179 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 19, 2024 

Received; read twice and referred to the Committee on Finance 

AN ACT 

To require the maintenance of the country of origin markings 

for imported goods produced in the West Bank or Gaza, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

HR 5179 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Anti-BDS Labeling 

3 Act’’. 

4 SEC. 2. CONTINUATION IN EFFECT OF COUNTRY OF ORIGIN 

5 MARKING POLICY FOR IMPORTED GOODS 

6 PRODUCED IN THE WEST BANK OR GAZA. 

7 The policy of the Government of the United States 

8 with respect to country of origin marking of imported 

9 goods produced in the West Bank or Gaza, notice of which 

10 was published by U.S. Customs and Border Protection in 

11 the Federal Register on December 23, 2020 (85 Fed. Reg. 

12 83984), shall remain in effect until repealed by an Act 

13 of Congress. 

14 SEC. 3. PROHIBITION ON USE OF FUNDS TO RESCIND OR 

15 CHANGE THE COUNTRY OF ORIGIN MARKING 

16 POLICY FOR IMPORTED GOODS PRODUCED 

17 IN THE WEST BANK OR GAZA. 

18 Notwithstanding any other provision of law, none of 

19 the funds authorized to be appropriated or otherwise made 

20 available for the Department of State or U.S. Customs 

21 and Border Protection on or after the date of the enact22 ment of this Act may be obligated or expended to prepare 

23 or promulgate any policy; guidance; regulation; notice; or 

24 Executive order or to otherwise implement, administer, or 

25 enforce any policy that rescinds or changes the policy of 

26 the Government of the United States with respect to counVerDate Sep 11 2014 01:07 Sep 20, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H5179.RFS H5179

ssavage on LAPJG3WLY3PROD with BILLS
3 

HR 5179 RFS

1 try of origin marking of imported goods produced in the 

2 West Bank or Gaza, notice of which was published by U.S. 

3 Customs and Border Protection in the Federal Register 

4 on December 23, 2020 (85 Fed. Reg. 83984). 

Passed the House of Representatives September 18, 

2024. 

Attest: KEVIN F. MCCUMBER, 

Clerk. 


ssavage on LAPJG3WLY3PROD with BILLS
#### STATE of Missouri, Plaintiff/Respondent, v. Kevin STANFIELD, Defendant/Appellant.

No. 66858

Missouri Court of Appeals, Eastern District, Division One.

Feb. 13, 1996.

Motion for Rehearing and/or Transfer to Supreme Court Denied March 25, 1996.

Keith G. Liberman, Clayton, for appellant.

John R. Lasater, Asst. Pros. Atty., St. Louis County, Clayton, for respondent.

Before REINHARD, P.J., and KAROHL and DOWD, JJ.

*ORDER*

PER CURIAM.

Defendant appeals after he was convicted following a bench trial of one count of harassment, § 565.090, RSMo 1986. The court sentenced him to a one year prison term but suspended execution of the sentence and placed defendant on probation for two years. We affirm. We have reviewed the record and find the claims of error to be without *265merit. An opinion would have no prece-dential value nor serve any jurisprudential purpose. The parties have been furnished with a memorandum for their information only, setting forth the reasons for this order pursuant to Rule 30.25(b).
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-22-00066-CV

R. K. S. and I. M., Appellants

v.

Texas Department of Family and Protective Services, Appellee

FROM THE 98TH DISTRICT COURT OF TRAVIS COUNTY

NO. D-1-FM-20-001541, THE HONORABLE MADELEINE CONNOR, JUDGE PRESIDING

O R D E R

PER CURIAM

Appellant R. K. S. filed her notice of appeal on February 9, 2022. The appellate 

record was complete on March 21, 2022, making appellant’s brief due on April 11, 2022. On 

April 11, 2022, counsel for appellant filed a first motion for extension of time seeking an 

additional 14 days to file appellant’s brief. On April 25, 2022, counsel for appellant filed a 

second motion for extension of time to file appellant’s brief.

The rules of judicial administration accelerate the final disposition of appeals 

from suits for termination of parental rights. See Tex. R. Jud. Admin. 6.2(a) (providing 180 days 

for court’s final disposition). The accelerated schedule constrains this Court’s leeway in granting 

extensions. In this instance, we dismiss as moot appellant’s first motion, grant appellant’s

second motion and order Karen J. Langsley to file appellant’s brief no later than May 2, 2022. If 
2

the brief is not filed by that date, counsel may be required to show cause why she should not be 

held in contempt of court.

It is ordered on April 28, 2022.

Before Justices Goodwin, Baker, and Triana
<TABLE> <S> <C>


<PAGE>
<PAGE>



<ARTICLE> 5
<LEGEND>

     This schedule contains summary  financial  information primarily  extracted
from  AT&T  Capital  Corporation's  audited  consolidated income  statement  and
balance  sheet  for and at the year ended December 31, 1995  and is qualified in
its entirety by reference to such financial statements.

         
</LEGEND
<MULTIPLIER>                                1,000
       
<S>                                   <C>
<PERIOD-TYPE>                         YEAR
<FISCAL-YEAR-END>                     DEC-31-1995
<PERIOD-END>                          DEC-31-1995
<CASH>                                      3,961
<SECURITIES>                                    0
<RECEIVABLES>                                   0
<ALLOWANCES>                             (223,220)
<INVENTORY>                                     0
<CURRENT-ASSETS>                                0 <F2>
<PP&E>                                          0
<DEPRECIATION>                           (642,728) <F1>
<TOTAL-ASSETS>                          9,541,259
<CURRENT-LIABILITIES>                           0 <F2>
<BONDS>                                 4,716,058
<COMMON>                                      470
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<OTHER-SE>                              1,115,655
<TOTAL-LIABILITY-AND-EQUITY>            9,541,259
<SALES>                                    48,724
<TOTAL-REVENUES>                        1,577,035
<CGS>                                      43,370
<TOTAL-COSTS>                             397,879
<OTHER-EXPENSES>                                0
<LOSS-PROVISION>                           86,214
<INTEREST-EXPENSE>                        411,040
<INCOME-PRETAX>                           208,239
<INCOME-TAX>                               80,684
<INCOME-CONTINUING>                       127,555
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                              127,555
<EPS-PRIMARY>                                2.70
<EPS-DILUTED>                                2.70
        

<FN>

<F1>  Accumulated depreciation relates to equipment under operating
       leases.

<F2>  This item is not applicable since the Company does not prepare a
       classified balance sheet.
</FN>
Exhibit 21.1

The SCO Group, Inc. Listing of Subsidiaries

|Subsidiary                       |  | Location      |  | Ownership Interest
|-------------------------------- |  | ------------- |  | ------------------
|SCO Operations, Inc.             |  | United States |  | Wholly-owned      
|SCO Global, Inc.                 |  | United States |  | Wholly-owned      
|SCO Software (Ireland) Ltd.      |  | Ireland       |  | Wholly-owned      
|SCO Japan, Ltd.                  |  | Japan         |  | Majority-owned    
|The SCO Group Korea, Inc.        |  | Korea         |  | Wholly-owned      
|SCO Canada, Inc.                 |  | Canada        |  | Wholly-owned      
|The SCO Group (Deutschland) GmbH |  | Germany       |  | Wholly-owned      
|The SCO Group (France) Sarl      |  | France        |  | Wholly-owned      
|The SCO Group (Italia) Srl       |  | Italy         |  | Wholly-owned      

---

QuickLinks
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5579 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 5579

 To provide that certain changes to the Manual of Military Decorations 
               and Awards shall have no force or effect.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 19, 2023

  Mr. Steube introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
 To provide that certain changes to the Manual of Military Decorations 
               and Awards shall have no force or effect.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preserve Military Recognition Act of 
2023''.

SEC. 2. PROHIBITION OF GENDER-NEUTRAL PRONOUN IN JOINT PERSONAL 
              MILITARY DECORATION CITATIONS.

    Changes to Figure 3 (regarding opening sentences for joint personal 
military decoration citations of the Department of Defense) of the 
Manual of Military Decorations and Awards: DoD Joint Decorations and 
Awards (Department of Defense Manual 1348.33, Vol. 4 (December 21, 
2016)) that became effective on August 7, 2023, and requires the use of 
the gender-neutral pronoun ``themself'' in joint personal military 
decoration citations of the Department of Defense, shall have no force 
or effect.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Career Development Awards—K99.                    

*Date:*                         July 14, 2021.                    

*Time:*                         11:30 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Lindsay M. Garvin, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Suite 208-Y, Bethesda, MD 20892, (301) 827-7911,                         *lindsay.garvin@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: June 4, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-12139 Filed 6-9-21; 8:45 am]

BILLING CODE 4140-01-P
CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002











In connection with the quarterly report of Kranem Corporation d/b/a Learningwire.com (the "Company") on Form 10-Q for the quarter ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Stephen K. Smith, acting in the capacity as the Chief Executive Officer, and I, Michael Grove,
accounting the capacity as the Chief Financial Officer of the Company, certify to the best of our knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.








/s/ Stephen K. Smith


Stephen K. Smith


Chief Executive Officer


November 16, 2009





/s/ Michael Grove


Michael Grove


Chief Financial Officer


November 16, 2009
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 07-6855

UNITED STATES OF AMERICA, Plaintiff - Appellee,
versus JACKIE MCKUBBIN, a/k/a Jack, Defendant - Appellant.
Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Richard L. Voorhees, District Judge. (3:95-cr-00005-3) Submitted: July 20, 2007 Decided: August 23, 2007 Before MICHAEL and KING, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Jackie McKubbin, Appellant Pro Se. Amy Elizabeth Ray, OFFICE OF THE UNITED STATES ATTORNEY, Asheville, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit.* For the purpose of this appeal, we assume that the date appearing on the notice of appeal is the earliest date it could have been properly delivered to prison officials for mailing to the court. Fed. R. App. P. 4(c); Houston v. Lack , 487 U.S. 266 (1988). - 2 - PER CURIAM: Jackie McKubbin seeks to appeal nunc pro tunc his conviction and life sentence imposed following his guilty plea to a drug conspiracy anda firearms charge. In criminal cases, the defendant must file the notice of appeal within ten days after the entry of judgment. Fed. R. App. P. 4(b)(1)(A). With or without a motion, upon a showing of excusable neglect or good cause, the district court may grant an extension of up to thirty days to file a notice of appeal. Fed. R. App. P. 4(b)(4); United States v. Reyes , 759 F.2d 351, 353 (4th Cir. 1985). The district court entered an amended judgment on September 15, 1999. The notice of appeal was filed on May 31, 2007. * Because McKubbin failed to file a timely notice of appeal or to obtain an extension of the appeal period, we dismiss the appeal for lack of jurisdiction. We deny McKubbin’s motions to rescind the informal briefing order, for appointment of counsel, and for reconsideration of the order deferring action on the motion for appointment of counsel. We dispense with oral argument because the facts and legal contentions are adequately presented in the- 3 - materials before the court and argument would not aid the decisional process.

DISMISSED
<PAGE>

                                                                    EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of OC Financial, Inc. (the "Company") on
Form 10-QSB for the quarter ending March 31, 2007 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Robert W. Hughes,
Chairman, President, and Chief Executive Officer and I, Danny E. Hosler, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934, as amended; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.


Date: May 15, 2007

/s/ Robert W. Hughes
--------------------
Robert W. Hughes
Chairman, President, and Chief Executive Officer


/s/ Danny E. Hosler
-------------------
Danny E.Hosler
Chief Financial Officer
[Federal Register Volume 60, Number 69 (Tuesday, April 11, 1995)]
[Notices]
[Pages 18415-18416]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-8899]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES


Agency for Health Care Policy and Research


Health Care Policy and Research Special Emphasis Panel; Notice of 
Meeting

    In accordance with section 10(a) of the Federal Advisory Committee 
Act (5 U.S.C. Appendix 2), announcement is made of the following 
special emphasis panel meeting scheduled for the month of May 1995:

    Name: Health Care Policy and Research, Special Emphasis Panel.
    Date and Time: May 23, 1995, 9:00 a.m.
    Place: Executive Office Center, 2101 East Jefferson Street, 6th 
Floor Conference Room 1, Rockville, Maryland 20852. This meeting 
will be closed to the public.
    Purpose: The Panel's charge is to provide advice and 
recommendations to the Secretary and to the Administrator, Agency 
for Health Care Policy and Research (AHCPR), regarding the 
scientific and technical merit of Phase II contract proposals 
submitted in response to a specific Request for Proposals (PHS 94-
2). The purpose of the Phase I contract, entitled Consumer Choices 
and Health Care Reform, was to determine factors important to 
consumers who make decisions about choosing health care plans, 
providers, and practitioners. The contractors were to develop a 
prototype decision support system, workbook, interactive video, or 
other tools for consumers to use when making these choices. The 
purpose of the Phase II contract is to develop an operational system 
with the capacity to be adapted to new categories of choices related 
to a reformed system of health care.
    Agenda: This meeting of the Panel will be devoted entirely to 
the technical review and evaluation of Phase II contract proposals 
submitted in response to a specific Request for Proposals. The 
Administrator, AHCPR, has made a formal determination that this 
meeting will not be open to the public. This is necessary to protect 
the free exchange of views and avoid undue interference with Panel 
and Department operations, and safeguard confidential proprietary 
[[Page 18416]] information and personal information concerning 
individuals associated with the proposals that may be revealed 
during the sessions. This is in accordance with section 10(d) of the 
Federal Advisory Committee Act, 5 U.S.C. Appendix 2, Department 
regulations, 45 CFR section 11.5(a)(6), and procurement regulations, 
48 CFR section 315.604(d).
    Anyone wishing to obtain information regarding this meeting 
should contact Frantz Wilson, Center for General Health Services 
Extramural Research, Division of Primary Care, Agency for Health 
Care Policy and Research, Executive Office Center, 2101 E. Jefferson 
Street, Suite 502, Rockville, Maryland 20852, (301) 594-1357 
extension 140.

    Dated: April 4, 1995.
Clifton R. Gaus,
Administrator.
[FR Doc. 95-8899 Filed 4-10-95; 8:45 am]
BILLING CODE 4160-90-M